HK1067382A1 - Combination of pdgf, kgf, and igfbp for wound healing - Google Patents
Combination of pdgf, kgf, and igfbp for wound healingInfo
- Publication number
- HK1067382A1 HK1067382A1 HK04110265A HK04110265A HK1067382A1 HK 1067382 A1 HK1067382 A1 HK 1067382A1 HK 04110265 A HK04110265 A HK 04110265A HK 04110265 A HK04110265 A HK 04110265A HK 1067382 A1 HK1067382 A1 HK 1067382A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pdgf
- kgf
- combination
- igfbp
- wound healing
- Prior art date
Links
- 230000029663 wound healing Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 abstract 3
- 230000037314 wound repair Effects 0.000 abstract 3
- 102000028416 insulin-like growth factor binding Human genes 0.000 abstract 1
- 108091022911 insulin-like growth factor binding Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/49—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1754—Insulin-like growth factor binding proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Materials Engineering (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US507595P | 1995-10-11 | 1995-10-11 | |
US2154096P | 1996-07-11 | 1996-07-11 | |
US71974296A | 1996-09-25 | 1996-09-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1067382A1 true HK1067382A1 (en) | 2005-04-08 |
Family
ID=27357798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04110265A HK1067382A1 (en) | 1995-10-11 | 2004-12-28 | Combination of pdgf, kgf, and igfbp for wound healing |
Country Status (11)
Country | Link |
---|---|
US (2) | US6903078B1 (es) |
EP (2) | EP0871730B1 (es) |
JP (2) | JPH11513405A (es) |
AT (1) | ATE274056T1 (es) |
AU (1) | AU7248896A (es) |
DE (2) | DE69637332T2 (es) |
DK (1) | DK1486565T3 (es) |
ES (2) | ES2293137T3 (es) |
HK (1) | HK1067382A1 (es) |
PT (2) | PT871730E (es) |
WO (1) | WO1997013857A1 (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1486565T3 (da) | 1995-10-11 | 2008-03-10 | Novartis Vaccines & Diagnostic | Kombination af PDGF, KGF, IGF og IGFBP til sårheling |
US6743422B1 (en) | 1996-10-15 | 2004-06-01 | Amgen, Inc. | Keratinocyte growth factor-2 products |
DE69727691T2 (de) * | 1996-10-15 | 2004-07-22 | Amgen Inc., Thousand Oaks | Verwendung von keratinocyten-wachstumsfaktor-2 |
EP1452205B1 (en) * | 1996-10-15 | 2007-11-28 | Amgen Inc. | Uses of keratinocyte growth factor-2 |
ATE296117T1 (de) | 1997-03-07 | 2005-06-15 | Wistar Inst | Verwendung von adenoviralen vektoren, die pdgf oder vegf exprimieren, zur heilung von gewebsdefekten und zur induzierung der hypervaskulität in säugergeweben |
US7217570B2 (en) | 2001-08-23 | 2007-05-15 | The Wistar Institute Of Anatomy And Biology | Organotypic intestinal culture and methods of use thereof |
US7202066B2 (en) * | 2002-01-29 | 2007-04-10 | Carrington Laboratories, Inc. | Combination of a growth factor and a protease enzyme |
WO2003068934A2 (en) * | 2002-02-14 | 2003-08-21 | Rutter William J | Chimeric molecules for cleavage in a treated host |
US20050224082A1 (en) * | 2004-04-05 | 2005-10-13 | Johnson Arthur A | Method for forming occlusive barrier over ear canal and kit for providing same |
US8114841B2 (en) | 2004-10-14 | 2012-02-14 | Biomimetic Therapeutics, Inc. | Maxillofacial bone augmentation using rhPDGF-BB and a biocompatible matrix |
US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
US20070004036A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for keratinocyte culture |
US20070003541A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for therapeutics |
US20070128685A1 (en) * | 2005-07-01 | 2007-06-07 | Rodolfo Faudoa | Methods and compositions for cell culture |
CA2641860C (en) | 2006-02-09 | 2015-07-14 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating bone |
GB0611405D0 (en) * | 2006-06-09 | 2006-07-19 | Univ Belfast | FKBP-L: A novel inhibitor of angiogenesis |
US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
ES2664229T3 (es) | 2006-06-30 | 2018-04-18 | Biomimetic Therapeutics, Llc | Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador |
US20080119433A1 (en) * | 2006-07-06 | 2008-05-22 | Aaron Thomas Tabor | Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance |
EP3181157B1 (en) | 2006-11-03 | 2019-08-14 | BioMimetic Therapeutics, LLC | Compositions and methods for arthrodetic procedures |
EP2091557A2 (en) | 2006-11-15 | 2009-08-26 | Coda Therapeutics, INC. | Improved methods and compositions for wound healing |
US20080195476A1 (en) * | 2007-02-09 | 2008-08-14 | Marchese Michael A | Abandonment remarketing system |
JP2011507856A (ja) * | 2007-12-21 | 2011-03-10 | コーダ セラピューティクス, インコーポレイテッド | 整形外科状態の治療のための抗コネキシンポリヌクレオチド、ペプチド、または抗体の使用 |
EP2234656A2 (en) | 2007-12-21 | 2010-10-06 | Coda Therapeutics, Inc. | Improved medical devices |
US20110130710A1 (en) * | 2007-12-21 | 2011-06-02 | David Lawrence Becker | Treatment of abnormal or excessive scars |
CN105854074B (zh) | 2008-02-07 | 2019-10-15 | 生物模拟治疗有限责任公司 | 用于牵引成骨术的组合物和方法 |
KR101021197B1 (ko) * | 2008-04-11 | 2011-03-11 | (주)케어젠 | 성장인자―미미킹 펩타이드 및 그의 용도 |
AU2009291828C1 (en) | 2008-09-09 | 2016-03-17 | Biomimetic Therapeutics, Llc | Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries |
EP2403514A4 (en) * | 2009-03-05 | 2012-11-14 | Biomimetic Therapeutics Inc | Platelet-derived growth factor compositions and methods of treating osteocartilaginous defects |
CN102471769A (zh) | 2009-07-17 | 2012-05-23 | 亚伦·T.·塔波尔 | 用于具有美容功能的细胞的遗传修饰以提高美容外观的方法和组合物 |
US8492335B2 (en) | 2010-02-22 | 2013-07-23 | Biomimetic Therapeutics, Llc | Platelet-derived growth factor compositions and methods for the treatment of tendinopathies |
US10279007B2 (en) | 2010-11-15 | 2019-05-07 | Oxygenetix Institute, Inc. | Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs |
EP3062889A2 (en) | 2013-11-01 | 2016-09-07 | Spherium Biomed S.L. | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents |
CN107109410B (zh) | 2014-08-22 | 2021-11-02 | 奥克兰联合服务有限公司 | 通道调节剂 |
EP3206670A4 (en) | 2014-10-14 | 2018-06-20 | Samuel Lynch | Compositions for treating wounds |
CN110590930B (zh) * | 2018-06-13 | 2023-03-31 | 四川好医生攀西药业有限责任公司 | 美洲大蠊生长因子pdgf在制备损伤修复药物中的应用 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3486216T2 (de) | 1983-04-25 | 1994-02-17 | Chiron Corp | Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren. |
US5187263A (en) | 1984-10-12 | 1993-02-16 | Zymogenetics, Inc. | Expression of biologically active PDGE analogs in eucaryotic cells |
US4801542A (en) * | 1984-10-12 | 1989-01-31 | Zymogenetics, Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
US4766073A (en) * | 1985-02-25 | 1988-08-23 | Zymogenetics Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
ATE131532T1 (de) * | 1986-08-13 | 1995-12-15 | Zymogenetics Inc | Expression von biologisch-aktiven pdgf-analogen in eukaryotischen zellen |
JPH01500199A (ja) | 1986-11-14 | 1989-01-26 | インスティチュート・オブ・モレキュラー・バイオロジー・インコーポレーテッド | 創傷の治癒および骨の再生 |
CA1322714C (en) | 1986-11-14 | 1993-10-05 | Harry N. Antoniades | Wound healing and bone regeneration |
US5019559A (en) | 1986-11-14 | 1991-05-28 | President And Fellows Of Harvard College | Wound healing using PDGF and IGF-II |
US4885163A (en) | 1987-02-24 | 1989-12-05 | Eli Lilly And Company | Topical use of IGF-II for wound healing |
US5422120A (en) * | 1988-05-30 | 1995-06-06 | Depotech Corporation | Heterovesicular liposomes |
ATE197800T1 (de) | 1989-01-31 | 2000-12-15 | Jeffrey S Rubin | Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor |
US5035887A (en) | 1989-09-07 | 1991-07-30 | Institute Of Moelcular Biology, Inc. | Wound healing composition of IL-1 and PDGF or IGF-1 |
US5149792A (en) * | 1989-12-19 | 1992-09-22 | Amgen Inc. | Platelet-derived growth factor B chain analogs |
JPH04224522A (ja) * | 1990-04-27 | 1992-08-13 | Merck & Co Inc | 繊維芽細胞増殖因子含有組成物による禿頭症の治療又は予防方法 |
ES2055611T3 (es) * | 1990-07-23 | 1994-08-16 | Zymogenetics Inc | Pdgf resistente a proteasas y metodos de uso. |
EP0546074B1 (en) | 1990-08-28 | 2001-11-14 | Chiron Corporation | Genetic material encoding igfbp-5 |
EP0546110B1 (en) | 1990-08-28 | 2001-11-14 | Chiron Corporation | New insulin-like growth factor binding protein igfbp-5 |
US5212074A (en) | 1990-08-28 | 1993-05-18 | Chiron Corporation | Genetic material encoding new insulin-like growth factor binding protein igfbp-6 |
DE69233155T2 (de) | 1991-01-08 | 2004-06-03 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | Insulinartigen wachstumsfaktor bindendes protein |
EP0526630A4 (en) * | 1991-02-22 | 1993-08-11 | Amgen Inc. | Use of gm-csf and g-csf to promote accelerated wound healing |
JP2527896B2 (ja) | 1991-04-19 | 1996-08-28 | ベーリンガー・マンハイム・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | ヒト骨由来インスリン様成長因子結合タンパク |
HUT67319A (en) | 1991-08-30 | 1995-03-28 | Life Medical Sciences Inc | Compositions for treating wounds |
IL105529A0 (en) | 1992-05-01 | 1993-08-18 | Amgen Inc | Collagen-containing sponges as drug delivery for proteins |
WO1994004030A1 (en) * | 1992-08-26 | 1994-03-03 | Celtrix Pharmaceuticals, Inc. | Method for systemic treatment of catabolic conditions and systemic tissue injury |
US5407913A (en) | 1992-12-03 | 1995-04-18 | Celtrix Pharmaceuticals, Inc. | Method and composition for systemic treatment of tissue injury |
EP0686040A1 (en) * | 1993-01-29 | 1995-12-13 | Amgen Boulder Inc. | Wound healing composition |
KR100390340B1 (ko) * | 1993-03-26 | 2003-09-26 | 암겐 인코포레이티드 | 케라티노사이트성장인자산물을함유하는제약학적조성물 |
US5750365A (en) * | 1993-05-28 | 1998-05-12 | The Ohio State University Research Foundation | Isolated nucleic acid encoding a newt acidic fibroblast growth factor (AFGF) |
ES2227527T3 (es) | 1993-06-29 | 2005-04-01 | Chiron Corp | Un factor de crecimiento de queratinocitos (kgf) truncado que tiene actividad biologica aumentada. |
US5624893A (en) | 1993-10-14 | 1997-04-29 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation |
US5962427A (en) * | 1994-02-18 | 1999-10-05 | The Regent Of The University Of Michigan | In vivo gene transfer methods for wound healing |
DK1486565T3 (da) | 1995-10-11 | 2008-03-10 | Novartis Vaccines & Diagnostic | Kombination af PDGF, KGF, IGF og IGFBP til sårheling |
-
1996
- 1996-09-27 DK DK04019502T patent/DK1486565T3/da active
- 1996-09-27 DE DE69637332T patent/DE69637332T2/de not_active Expired - Lifetime
- 1996-09-27 ES ES04019502T patent/ES2293137T3/es not_active Expired - Lifetime
- 1996-09-27 AU AU72488/96A patent/AU7248896A/en not_active Abandoned
- 1996-09-27 DE DE69633194T patent/DE69633194T2/de not_active Expired - Lifetime
- 1996-09-27 ES ES96933952T patent/ES2224178T3/es not_active Expired - Lifetime
- 1996-09-27 WO PCT/US1996/015623 patent/WO1997013857A1/en active IP Right Grant
- 1996-09-27 AT AT96933952T patent/ATE274056T1/de active
- 1996-09-27 PT PT96933952T patent/PT871730E/pt unknown
- 1996-09-27 EP EP96933952A patent/EP0871730B1/en not_active Expired - Lifetime
- 1996-09-27 EP EP04019502A patent/EP1486565B1/en not_active Expired - Lifetime
- 1996-09-27 PT PT04019502T patent/PT1486565E/pt unknown
- 1996-09-27 JP JP9515071A patent/JPH11513405A/ja not_active Withdrawn
-
2000
- 2000-11-27 US US09/723,449 patent/US6903078B1/en not_active Expired - Fee Related
-
2004
- 2004-12-28 HK HK04110265A patent/HK1067382A1/xx not_active IP Right Cessation
-
2005
- 2005-05-02 US US11/120,154 patent/US20050250695A1/en not_active Abandoned
-
2007
- 2007-04-11 JP JP2007104234A patent/JP2007182461A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE69633194T2 (de) | 2005-09-08 |
DE69633194D1 (de) | 2004-10-21 |
EP1486565B1 (en) | 2007-11-21 |
US6903078B1 (en) | 2005-06-07 |
DK1486565T3 (da) | 2008-03-10 |
PT1486565E (pt) | 2008-02-28 |
AU7248896A (en) | 1997-04-30 |
ES2293137T3 (es) | 2008-03-16 |
JP2007182461A (ja) | 2007-07-19 |
EP0871730B1 (en) | 2004-08-18 |
PT871730E (pt) | 2004-11-30 |
US20050250695A1 (en) | 2005-11-10 |
WO1997013857A1 (en) | 1997-04-17 |
DE69637332T2 (de) | 2008-10-09 |
DE69637332D1 (de) | 2008-01-03 |
ATE274056T1 (de) | 2004-09-15 |
EP0871730A1 (en) | 1998-10-21 |
EP1486565A1 (en) | 2004-12-15 |
JPH11513405A (ja) | 1999-11-16 |
ES2224178T3 (es) | 2005-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1067382A1 (en) | Combination of pdgf, kgf, and igfbp for wound healing | |
EP2270047A3 (en) | Anti-C5 antibodies and their therapeutic uses | |
EP0839542A3 (en) | Process and apparatus for coating surgical sutures | |
PL332541A1 (en) | D-olanzapin dihydrate | |
AU5424596A (en) | Microminiature illuminator for administering photodynamic therapy | |
AU7324394A (en) | Bone cement delivery gun | |
AU6757794A (en) | Parathyroid hormone and raloxifene for increasing bone mass | |
FR05C0027I2 (es) | ||
AU6212094A (en) | Anti-stall tip treatment means | |
AU1467897A (en) | Multipiece interfragmentary fixation assembly | |
EP0675723A4 (en) | BIPHOSPHONATE / ESTROGEN THERAPY FOR TREATING AND PREVENTING BONE LOSS. | |
EP0576991A3 (en) | Monitoring device for a fluorescent tube. | |
AU1347995A (en) | Method of improving the immune response | |
BR9813996A (pt) | 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio | |
GR3029436T3 (en) | Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds. | |
AU2807492A (en) | Use of misoprostol for the treatment of allergy | |
ZA966578B (en) | Pharmaceutical composition. | |
AU1498395A (en) | Novel protease for treating devitalized tissue | |
AP9200355A0 (en) | "Therapeutic agent" | |
AU1278600A (en) | Novel therapeutic application of nicergoline | |
AU3274697A (en) | Wound healing accelerators | |
AU1506692A (en) | Pharmaceutical compositions | |
GB9300644D0 (en) | Composition for accelerating wound healing | |
MY140504A (en) | Statin-mmp inhibitor combinations | |
GB9521527D0 (en) | Controlling lamps |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110927 |